{
  "docId": "019de516-9989-7672-a652-fe437099830c",
  "docSlug": "dc4b6dd31d750eecf6a392f7e2ae4db2",
  "documentTitle": "MaxCyte | Investor Presentation Deck | 22 slides",
  "authorId": "maxcyte",
  "authorName": "MaxCyte",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-08-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 6,
  "pageCount": 22,
  "prevPage": 5,
  "nextPage": 7,
  "slideType": "business_model",
  "function": "present_framework",
  "density": "overcrowded",
  "nDataPoints": 1,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de516-9989-7672-a652-fe437099830c/6",
  "deckHref": "/decks/019de516-9989-7672-a652-fe437099830c",
  "deckJsonHref": "/decks/019de516-9989-7672-a652-fe437099830c.json",
  "deckAnchorHref": "/decks/019de516-9989-7672-a652-fe437099830c#slide-6",
  "components": [
    {
      "bbox": {
        "h": 0.69,
        "w": 0.42,
        "x": 0.515,
        "y": 0.142
      },
      "kind": "chart",
      "text": "Cumulative Potential Pre-CML Milestones\nPotential Value of Pre-Commercial Milestones: ~$2B USD\n2017, 2018, 2019, 2020, 2021, 2022, 2023",
      "attrs": {
        "chart_type": "line"
      },
      "subkind": "line",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b0a655af-9ccf-4cb4-aa5a-40e3bc4a7d67",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.336,
        "x": 0.144,
        "y": 0.47
      },
      "kind": "list",
      "text": "Sales-based payments upon partner's product commercialization",
      "attrs": {},
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "658de4ee-239d-49d3-8cc7-5519cc83cc74",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.336,
        "x": 0.144,
        "y": 0.75
      },
      "kind": "list",
      "text": "Milestone revenue is MaxCyte's highest growth revenue stream",
      "attrs": {},
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "730228e1-c0e3-4da3-8c80-5597cf055509",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.336,
        "x": 0.144,
        "y": 0.59
      },
      "kind": "list",
      "text": "Recurring revenues from lease of instruments and sales of single-use disposables that grow with program success",
      "attrs": {},
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a9b09984-a03c-451a-8dff-73b4c6e9f335",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.336,
        "x": 0.144,
        "y": 0.35
      },
      "kind": "list",
      "text": "Potential value of pre-commercial (clinical development) milestones from SPLs: ~$2B",
      "attrs": {},
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b09217be-f079-462d-960b-9e550b10d8dc",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.336,
        "x": 0.144,
        "y": 0.19
      },
      "kind": "paragraph",
      "text": "Licensing deals include significant development milestones and high-value participation in future commercial success of partners",
      "attrs": {},
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "328ac232-2d6f-4061-8b97-2bdb07f89ced",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.01,
        "w": 0.249,
        "x": 0.604,
        "y": 0.845
      },
      "kind": "source-note",
      "text": "Graph is provided for illustrative purposes only.",
      "attrs": {},
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "066c4d1b-44db-4b0a-99b7-b84c694f4cf1",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.41,
        "x": 0.08,
        "y": 0.839
      },
      "kind": "source-note",
      "text": "**Casebia/CRISPR's SPL partnership (signed in 2017) included the rights to use MaxCyte's technology in the development of exa-cel (formerly known as CTX001). As announced in the press release on September 28th, 2022, Vertex has signed an SPL agreement with MaxCyte - Vertex has obtained the clinical and commercial rights to use MaxCyte's technology for the development of exa-cel (formerly known as CTX001).",
      "attrs": {},
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a9fb92cd-e4ab-4aad-9ecf-c47fea6e6217",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.307,
        "x": 0.042,
        "y": 0.065
      },
      "kind": "title",
      "text": "Value Creation from SPLs",
      "attrs": {},
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b84b3564-3ab1-47de-94d7-8fe232769360",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Waterfall chart",
      "slug": "waterfall-chart",
      "agent": null,
      "layer": "slide",
      "matchId": "f26c601d-2466-4f70-a94b-84ed8df29150",
      "evidence": "The slide mentions 'Cumulative Potential Pre-CML Milestones' and a line chart, which could represent a waterfall chart.",
      "confidence": 0.8
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 11,
      "from": 6,
      "beatId": "d4f7f81d-15bd-4167-9e08-bd7e1ed530d3",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Business Model",
      "beatSlug": "sequoia-pitch-business-model",
      "evidence": "The business model is explained on pages 6 and 10-11",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": "Evidence",
      "parentBeatSlug": "evidence"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}